Found: 13
Select item for more details and to access through your institution.
The 48-week efficacy of once-daily saquinavir/ritonavir in patients with undetectable viral load after 3 years of antiretroviral therapy.
- Published in:
- HIV Medicine, 2005, v. 6, n. 2, p. 122, doi. 10.1111/j.1468-1293.2005.00274.x
- By:
- Publication type:
- Article
Patient characteristics and costs associated with dyslipidaemia and related conditions in HIV-infected patients: a retrospective cohort study.
- Published in:
- HIV Medicine, 2005, v. 6, n. 2, p. 79, doi. 10.1111/j.1468-1293.2005.00269.x
- By:
- Publication type:
- Article
Factors associated with virological response in HIV-infected patients failing antiretroviral therapy: a prospective cohort study.
- Published in:
- HIV Medicine, 2005, v. 6, n. 2, p. 129, doi. 10.1111/j.1468-1293.2005.00275.x
- By:
- Publication type:
- Article
There and back again: the impact of adult HIV prevalence on national life expectancies.
- Published in:
- 2005
- By:
- Publication type:
- Letter
Impact of highly active antiretroviral therapy on organ-specific manifestations of HIV-1 infection.
- Published in:
- HIV Medicine, 2005, v. 6, n. 2, p. 66, doi. 10.1111/j.1468-1293.2005.00268.x
- By:
- Publication type:
- Article
Effects of HIV disease on lipid, glucose and insulin levels: results from a large antiretroviral-naïve cohort.
- Published in:
- 2005
- By:
- Publication type:
- Journal Article
Enhanced glucagon-like peptide-1 (GLP-1) response to oral glucose in glucose-intolerant HIV-infected patients on antiretroviral therapy.
- Published in:
- HIV Medicine, 2005, v. 6, n. 2, p. 91, doi. 10.1111/j.1468-1293.2005.00270.x
- By:
- Publication type:
- Article
Ethnic differences in stage of presentation of adults newly diagnosed with HIV-1 infection in south London.
- Published in:
- HIV Medicine, 2005, v. 6, n. 2, p. 59, doi. 10.1111/j.1468-1293.2005.00267.x
- By:
- Publication type:
- Article
Effects of HIV disease on lipid, glucose and insulin levels: results from a large antiretroviral-naïve cohort.
- Published in:
- HIV Medicine, 2005, v. 6, n. 2, p. 114, doi. 10.1111/j.1468-1293.2005.00273.x
- By:
- Publication type:
- Article
Comparison of gastrointestinal tolerability and patient preference for treatment with the 625 mg and 250 mg nelfinavir tablet formulations.
- Published in:
- HIV Medicine, 2005, v. 6, n. 2, p. 107, doi. 10.1111/j.1468-1293.2005.00272.x
- By:
- Publication type:
- Article
Changing mortality rates and causes of death for HIV-infected individuals living in Southern Alberta, Canada from 1984 to 2003.
- Published in:
- HIV Medicine, 2005, v. 6, n. 2, p. 99, doi. 10.1111/j.1468-1293.2005.00271.x
- By:
- Publication type:
- Article
Mitochondrial DNA depletion in liver tissue of patients infected with hepatitis C virus: contributing effect of HIV infection?
- Published in:
- HIV Medicine, 2005, v. 6, n. 2, p. 135, doi. 10.1111/j.1468-1293.2005.00276.x
- By:
- Publication type:
- Article
The prevalence and risk of immune restoration disease in HIV-infected patients treated with highly active antiretroviral therapy.
- Published in:
- HIV Medicine, 2005, v. 6, n. 2, p. 140, doi. 10.1111/j.1468-1293.2005.00277.x
- By:
- Publication type:
- Article